Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac

Launched by UNIVERSITY HOSPITAL TUEBINGEN · Nov 19, 2019

Keywords

ClinConnect Summary

This clinical trial is exploring a new type of cancer treatment using a special machine called a 1.5T MR-Linac, which combines MRI imaging with radiation therapy. The goal is to see how well this technology can help treat patients with various types of cancer, including rectal, head and neck, liver, breast, prostate cancers, and more. The trial is currently looking for participants, and there is no upper age limit, although participants must be at least 18 years old and able to give their consent to join the study.

To be eligible, you should already be advised to receive radiation therapy and not have any conditions that would prevent you from undergoing an MRI, such as claustrophobia or certain metal implants. If you join the trial, you can expect to receive treatment using this advanced technology, which aims to improve how radiation is delivered to cancer cells while minimizing damage to healthy tissue. It's an exciting opportunity for patients looking for innovative treatment options in their fight against cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • existing indication for radiation therapy
• • minimum age 18 years, no upper age limit
• • capacity for consent
• • Informed consent
• Exclusion Criteria:
• • contraindication for MRI (claustrophobia, metallic implants not applicable for MRI
• • pregnancy